Wearable cardioverter defibrillator in stress cardiomyopathy and cardiac arrest

Nascimento, Francisco O.; Krishna, Rama K.; Hrachian, Hakop H.; Santana, Orlando

doi:10.1136/bcr-2013-009789

Cited by 6 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The incidence of shock, resuscitation, and death is comparable to that in age-and gender-matched patients with ACS [4]. Selected patients might be candidates for a wearable defibrillator until recovery of LV wall motion abnormalities [120][121][122]. Cardiogenic shock occurs in around 10% of patients with TS.…”

Section: In-hospital Complicationsmentioning

confidence: 96%

Takotsubo syndrome: between evidence, myths, and misunderstandings

Napp

Bauersachs

2020

Herz

View full text Add to dashboard Cite

Takotsubo syndrome (TS) is an acute cardiac condition characterized by transient wall motion abnormalities mostly of the left ventricle. First described in 1990, TS has gained substantial attention during the past 15 years. However, the disease is still underdiagnosed. Prospective studies on TS are largely lacking, and the condition remains incompletely understood. In addition, significant misconceptions and misunderstandings are evident, contributing to potentially severe underestimation. Here, we review important aspects of TS with a focus on pitfalls, misinterpretations, and knowledge gaps considered important during diagnosis and management of the disease.

show abstract

Section: In-hospital Complicationsmentioning

confidence: 96%

Takotsubo syndrome: between evidence, myths, and misunderstandings

Napp

Bauersachs

2020

Herz

View full text Add to dashboard Cite

show abstract

“…A 57-year-old woman with TTS and markedly prolonged QTc (883 ms) developed cardiac arrest due to polymorphic VT in the form of TdP requiring defibrillation. 174 The LVEF was at 20%. She was managed supportively, including a transvenous temporary pacemaker.…”

Section: Treatment and Prophylaxismentioning

confidence: 98%

Takotsubo Syndrome and Sudden Cardiac Death

Manolis

Manolis²,

Melita

et al. 2022

Angiology

View full text Add to dashboard Cite

Takotsubo syndrome (TTS), triggered by intense emotional or physical stress, occurring most commonly in post-menopausal women, presents as an ST-elevation myocardial infarction (MI). Cardiovascular complications occur in almost half the patients with TTS, and the inpatient mortality is comparable to MI (4–5%) owing to cardiogenic shock, myocardial rupture, or life-threatening arrhythmias. Thus, its prognosis is not as benign as previously thought, as it may cause mechanical complications (cardiac rupture) and potentially lethal arrhythmias and sudden cardiac death (SCD). Similar to MI, some patients may perish before reaching the hospital due to out-of-hospital cardiac arrest; this may lead to underestimation of the actual SCD risk. Furthermore, after discharge, some patients may develop late SCD and/or TTS recurrence that may result in SCD. There are risk factors for SCD in TTS patients, such as severe/persistent QT-interval prolongation inciting torsade-de-pointes, other ECG abnormalities (diffuse giant negative T-waves, widened QRS-complex), bradyarrhythmias, comorbidities, concurrent obstructive coronary artery disease or vasospasm, male gender, older age, severe left ventricular dysfunction, and use of sympathomimetic drugs. All these issues are herein reviewed, case reports/series and data from large cohort studies and meta-analyses are analyzed, risk factors are tabulated, and proarrhythmic effects and management strategies are discussed and pictorially illustrated.

show abstract

“…Patients with QT prolongation after stress cardiomyopathy demonstrated a higher risk of VA. This subset of patients might have substantial benefit of the WCD use[ 39 , 40 ].…”

Section: Clinical Studiesmentioning

confidence: 99%

Wearable cardioverter defibrillator: Bridge or alternative to implantation?

Barraud¹,

Cautela²,

Orabona³

et al. 2017

WJC

View full text Add to dashboard Cite

The implantable cardioverter-defibrillator (ICD) is effective to prevent sudden cardiac death (SCD) in selected patients with heart disease known to be at high risk for ventricular arrhythmia. Nevertheless, this invasive and definitive therapy is not indicated in patients with potentially transient or reversible causes of sudden death, or in patients with temporary contra-indication for ICD placement. The wearable cardioverter defibrillator (WCD) is increasingly used for SCD prevention both in patients awaiting ICD implantation or with an estimated high risk of ventricular arrhythmia though to be transient. We conducted a review of current clinical uses and benefits of the WCD, and described its technical aspects, limitations and perspectives.

show abstract

Wearable cardioverter defibrillator in stress cardiomyopathy and cardiac arrest

Cited by 6 publications

References 7 publications

Takotsubo syndrome: between evidence, myths, and misunderstandings

Takotsubo syndrome: between evidence, myths, and misunderstandings

Takotsubo Syndrome and Sudden Cardiac Death

Wearable cardioverter defibrillator: Bridge or alternative to implantation?

Contact Info

Product

Resources

About